Also trades as: 1951.HK (HKSE) · $vol 4M

$0.29

+0.00 (+0.00%)

OTC · Healthcare · Medical - Care Facilities · Tech Score Sell · Power 46 · $740.3M mcap · 2.11B float · 0.0001% daily turnover

Revenue

$2.6B -8.2% ▼

5Y CAGR: +12.6%

Gross Profit

$818M -25.6% ▼

5Y CAGR: +7.7%

Operating Income

$198M -56.4% ▼

5Y CAGR: -3.6%

Net Income

-$951M -435.9% ▼

EPS (Diluted)

$-0.35 -450.0% ▼

EBITDA

$539M -25.8% ▼

5Y CAGR: +10.2%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$1.8B	$2.4B	$2.8B	$2.8B	$2.6B
YoY Growth	+28.9%	+28.6%	+18.0%	+0.8%	-8.2%
Cost of Revenue	$1.1B	$1.5B	$1.6B	$1.7B	$1.8B
Gross Profit	$771M	$913M	$1.2B	$1.1B	$818M
Gross Margin	42.0%	38.6%	42.1%	39.1%	31.7%
R&D Expenses	$11M	$17M	$22M	$25M	$20M
SG&A Expenses	$389M	$610M	$673M	$633M	$600M
Operating Expenses	$400M	$628M	$695M	$646M	$621M
Operating Income	$371M	$285M	$480M	$454M	$198M
Operating Margin	20.2%	12.1%	17.2%	16.1%	7.7%
Interest Expense	$21M	$72M	$80M	$57M	$69M
Income Before Tax	$458M	$154M	$464M	$392M	-$958M
Tax Expense	$104M	$36M	$117M	$118M	$900K
Net Income	$340M	$121M	$345M	$283M	-$951M
Net Margin	18.5%	5.1%	12.4%	10.1%	-36.8%
EPS (Diluted)	$0.14	$0.05	$0.12	$0.10	$-0.35
EBITDA	$494M	$476M	$682M	$726M	$539M
Shares Outstanding	2.50B	2.62B	2.74B	2.72B	2.74B

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$1.2B	$1.3B	$1.5B	$1.4B	$1.4B	$1.3B	$1.3B	$1.4B
Cost of Revenue	$777M	$770M	$844M	$861M	$851M	$897M	$874M	$871M
Gross Profit	$449M	$564M	$611M	$583M	$516M	$391M	$464M	$483M
Gross Margin	36.6%	42.3%	42.0%	40.4%	37.8%	30.4%	34.7%	35.7%
R&D Expenses	$13M	$11M	$11M	$11M	$14M	$9M	$11M	$12M
SG&A Expenses	$369M	$275M	$398M	$302M	$331M	$392M	$341M	$278M
Operating Expenses	$503M	$259M	$409M	$313M	$345M	$401M	$352M	$290M
Operating Income	$67M	$278M	$202M	$270M	$171M	-$9M	$112M	$194M
Operating Margin	5.5%	20.9%	13.9%	18.7%	12.5%	-0.7%	8.4%	14.3%
Interest Expense	$0	$0	$0	$0	$26M	$39M	$28M	$57M
Income Before Tax	-$79M	$279M	$186M	$266M	$126M	-$1.1B	$104M	$153M
Tax Expense	-$10M	$55M	$63M	$75M	$43M	$44M	$45M	$44M
Net Income	-$69M	$224M	$121M	$190M	$93M	-$1.0B	$63M	$106M
Net Margin	-5.6%	16.8%	8.3%	13.1%	6.8%	-80.7%	4.7%	7.8%
EPS (Diluted)	$-0.03	$0.08	$0.04	$0.07	$0.03	$-0.38	$0.03	$0.04
EBITDA	$176M	$370M	$312M	$370M	$275M	$114M	$293M	$361M
Shares Outstanding	2.63B	2.73B	2.74B	2.70B	2.74B	2.68B	1.98B	2.65B

JXFGF OTC